In neurofibromatosis type-1 (NF1), cerebrovascular disorders are rarely encountered although vasculopathy is a well-known complication. Several mutations seen in methylenetetrahydrofolate reductase (MTHFR) give rise to the formation of hyperhomocysteinemia and homocystinuria, a considerable risk factor for cardiovascular and cerebrovascular disorders, by leading to enzymatic inactivation. In the paper, a 31-year-old young stroke female patient with the coexistence of neurofibromatosis and MTHFR C677T gene mutation was presented.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600223 | PMC |
| http://dx.doi.org/10.1155/2013/735419 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Patient With Intracranial Multiple Meningiomas Combined With Neurofibromatosis type I.
J Craniofac Surg
January 2025
Department of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army.
The coexistence of intracranial multiple meningiomas and neurofibromatosis type 1 is a rare occurrence in the field of neurosurgery, presenting complex treatment challenges, unfavorable prognoses, and significant burdens on both families and society. Currently, the primary objective is to perform surgical total resection as far as possible, while considering postoperative adjuvant radiotherapy for cases where complete tumor resection is challenging. In this case, the patient has previously undergone multiple brain tumor resections and received radiation therapy.
View Article and Find Full Text PDFGene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research.
Glob Med Genet
December 2024
Department of General Surgery, Tianjin Union Medical Center, Tianjin, People's Republic of China.
Article Synopsis
- - Gastrointestinal stromal tumors (GISTs) are more frequently diagnosed in older patients, and they primarily feature mutations in receptor tyrosine kinase (KIT) or platelet-derived growth factor receptor a (PDGFRA) in about 75% and 15% of cases, respectively.
- - Tumors lacking these mutations are classified as "wild type" (WT)-GISTs, which can have other genetic alterations and account for around 15% of GIST cases, including a subtype called "quadruple WT" GISTs that show no known mutations.
- - Treatment for GISTs varies based on genetic subtypes, with imatinib mesylate being the main first-line drug for advanced
Bilateral vestibular schwannoma with a cooccurring meningioma in a child: a case report and review of literature.
Ann Med Surg (Lond)
July 2024
No department Ministry of Health and Population, Kathmandu, Nepal.
Article Synopsis
- - Meningioma and vestibular schwannoma (VS) are the two most common benign CNS tumors, and their simultaneous occurrence is rare, especially in pediatric patients, as illustrated by a case of a 15-year-old Nepali boy.
- - The patient presented with symptoms like hearing loss and seizures, leading to a diagnosis of bilateral VS and meningioma; he underwent radiosurgery for the VS while the meningioma was managed non-operatively, resulting in improved symptoms.
- - Understanding the coexistence of these tumors is complex and under-researched, particularly regarding their genetic mechanisms, necessitating more studies to enhance treatment strategies and patient care.
First Co-Occurrence of Griscelli Syndrome Type 2 and Neurofibromatosis Type 1.
Mol Syndromol
June 2024
Department of Medical Genetics, Demiroglu Bilim University, Istanbul, Turkey.
Introduction: Griscelli syndrome type 2 (GS2) and neurofibromatosis type 1 (NF1) are both rare genetic disorders, but their coexistence has not been documented prior to this report.
Case Presentation: We present the case of a 4-year-old girl initially diagnosed with GS2 due to albinism and immunodeficiency, and later with NF1, manifested by the development of multiple café-au-lait macules (CALMs) and MRI findings. The patient was the second child of consanguineous parents and exhibited symptoms early, with silver-gray hair at birth and subsequent health complications at 9 months.
Case of embryonal tumor multilayered rosettes in a patient with neurofibromatosis type 1.
Childs Nerv Syst
August 2024
Section of Pediatric-Oncology, Department of Oncology, Aga Khan University Hospital Karachi, Stadium Road, Karsaz, Karachi, Pakistan.
Background: ETMR is a unique and highly malignant brain tumor mostly occurring in infants. This report provides a comprehensive overview of the clinical presentation, histological aspects, radiological features, and therapeutic options of ETMR. Being the first report on the co-occurrence of NF1 with ETMR, it highlight the challenges of managing a patient with complex medical conditions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!